drugset / Trial / NCT00699803

Study of T-PRED(TM) Compared to Pred Forte(R)

NCT00699803

Phase 2 Completed 64 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupQuadruple-blindBasic science

Summary

Study of T-PRED(TM) compared to Pred Forte(R)

Timeline

Start
2008-05
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified
Subject Tobramycin Small molecule

Indications